CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Accounting Officer sold 209 shares at an average $1.59 ($333)
- 4 Open-market sale Chief Development Officer sold 431 shares at an average $1.59 ($687)
- 4 Open-market sale Chief Commercial Officer sold 465 shares at an average $1.59 ($741)
- 4 Open-market sale President & CEO sold 3,744 shares at an average $1.59 ($5,966)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 975 shares at an average $1.59 ($1,554)
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 26,368 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Accounting Officer acquired 880 shares (option exercise)
- 4 Option exercise Director acquired 347,840 shares (option exercise)
- 4 Option exercise Director acquired 86,960 shares (option exercise)
Page 9 of 31 · 602 filings